RE:NEW CORPORATE PRESENTATION (TIMELINES)this presentation was created for the BIO Europe virtual conference that took place earlier...hence the October date on the presentation. From what we can see BTI has a new drug: XB3 combined with Progranulin, potentially for the treatment of Frontotemporal Dementia.